Northwest Biotherapeutics, Inc. (BST:NBYB)

Northwest Biotherapeutics Revenue

Northwest Biotherapeutics had revenue of $131.00K USD in the quarter ending June 30, 2025, a decrease of -74.31%. This brings the company's revenue in the last twelve months to $1.09M, down -33.50% year-over-year. In the year 2024, Northwest Biotherapeutics had annual revenue of $1.38M, down -28.47%.

• Revenue (ttm): $1.09M
• Revenue Growth: -33.50%
• P/S Ratio: 347.49
• Revenue / Employee: $43.76K
• Employees: 25
• Market Cap: 323.70M EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	1.38M	-550.00K	-28.47%
Dec 31, 2023	1.93M	249.00K	14.80%
Dec 31, 2022	1.68M	678.00K	67.46%
Dec 31, 2021	1.01M	-286.00K	-22.15%
Dec 31, 2020	1.29M	-1.12M	-46.43%